Large Volume Parenteral (LVP) Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Large Volume Parenteral (LVP) Market?
The market size of large volume parenteral (LVP) has witnessed considerable expansion in the recent past. The market, which is currently valued at $12.52 billion as of 2024, is projected to increase to $13.57 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The considerable growth during the historic period can largely be credited to the rising instances of chronic illnesses, an escalation in the elderly population, growing demand for germ-free pharmaceuticals, enhancement of healthcare provisions, and the establishment of regulatory directives in relation to pharmaceuticals.
What Growth Rate Is Forecasted for the Large Volume Parenteral (LVP) Market by 2029?
In the forthcoming years, robust growth is anticipated in the large volume parenteral (LVP) market. The market is projected to expand to $19.46 billion in 2029 with a 9.4% compound annual growth rate (CAGR). The forecasted growth can be linked to the escalating demand for biologics and biosimilars, augmented healthcare spending, broadening of pharmaceutical outsourcing, an amplified focus on personalized medicine, and internationalization of pharmaceutical supply chains. Key trends during the forecast period include advancements in manufacturing procedures, incorporation of cutting-edge technologies in drug production, application of single-use technologies, development of highly concentrated formulations, and an uptick in the use of 3D printing for pharmaceutical applications.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp
Which Key Companies Are Shaping the Future of the Large Volume Parenteral (LVP) Market?
Major companies operating in the large volume parenteral (LVP) market include Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Becton Dickinson and Company, Otsuka Holdings Co Ltd., Baxter International Inc., B Braun Melsungen AG, Grifols SA, Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Nelson Laboratories LLC, Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd, Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd, Pentagon Labs Ltd., DJ Labs Pvt Ltd., Higgs Healthcare.
Which Factors Are Driving Demand in the Large Volume Parenteral (LVP) Industry?
The surge in chronic ailments is anticipated to accelerate the expansion of the large-volume parenteral market. Chronic ailments are diseases or conditions that usually endure for three months or more and may intensify over time. The escalation in such diseases is primarily fueled by the usage of tobacco, exposure to smoke, and inadequate nutrition. These patients necessitate an optimal balance of vital nutrients that bolster the retention of strength. The parenteral method of administration ensures the correct pharmaceutical dosage as it lets most of the medication be directly absorbed into the bloodstream, bypassing the digestive system. To exemplify, as per the World Health Organization, a Switzerland-based specialized agency of the United Nations, in September 2023, there were 41 million deaths or 74% of the total deaths resulting from non-communicable diseases (NCDs) or chronic diseases globally each year. Hence, the escalating prevalence of chronic diseases boosts the expansion of the large-volume parenteral market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp
How Is the Large Volume Parenteral (LVP) Market Segmented by Several Divisions?
The large volume parenteral (LVP) market covered in this report is segmented –
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles
What are the Emerging Market Trends Driving the Growth of the Large Volume Parenteral (LVP) Industry?
Product innovation has catapulted to prominence as a primary trend in the large-volume parenteral market. Major participants in the market are channeling their energies towards the development of creative items to cement their market standing. For instance, SGD Pharma SA, a company based in France that specializes in the production of molded and tubular glass for primary pharmaceutical packaging, introduced 100-ml type I molded glass vials in March 2022. These vials are sterile and ready for the aseptic filling and finishing of parenteral medicinal solutions. This innovation not only prevents vial scratches but also aids in the visual inspection of the filled vial and reduces the chance of rejection in quality control.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Which Regions Are Driving Growth in the Large Volume Parenteral (LVP) Market?
North America was the largest region in the large volume parenteral (LVP) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (LVP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12195
This Report Delivers Insight On:
1. How big is the large volume parenteral (lvp) market, and how is it changing globally?
2. Who are the major companies in the large volume parenteral (lvp) market, and how are they performing?
3. What are the key opportunities and risks in the large volume parenteral (lvp) market right now?
4. Which products or customer segments are growing the most in the large volume parenteral (lvp) market?
5. What factors are helping or slowing down the growth of the large volume parenteral (lvp) market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
